GBA1 and Parkinson disease: The total carrier frequency of rare GBA1 variants predicted as “pathogenic”, “likely pathogenic”, or of “uncertain significance” was 17.1% (79/462) in the PD cases and 8.4% (31/367) in the controls (OR = 2.24 [1.44, 3.47]) (Table 2).